Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 15,985 | 11,799 | 12,524 | 14,034 | 13,434 |
| Operating Income | -14,957 | -11,799 | -12,524 | -14,034 | -13,434 |
| Interest Expense | 1,126 | 1,337 | 1,276 | 1,294 | 1,296 |
| Other Income | 361 | 414 | 439 | 549 | 675 |
| Pre-tax Income | -15,722 | -12,722 | -13,361 | -14,779 | -14,055 |
| Net Income Continuous | -15,722 | -12,722 | -13,361 | -14,779 | -14,055 |
| Minority Interests | -6,775 | -5,939 | -6,556 | -7,296 | -6,957 |
| Net Income | $-8,947 | $-6,783 | $-6,805 | $-7,483 | $-7,098 |
| EPS Basic Total Ops | -0.26 | -0.24 | -0.26 | -0.29 | -0.27 |
| EPS Basic Continuous Ops | -0.47 | -0.44 | -0.51 | -0.57 | -0.54 |
| EPS Diluted Total Ops | -0.26 | -0.24 | -0.26 | -0.29 | -0.27 |
| EPS Diluted Continuous Ops | -0.47 | -0.44 | -0.51 | -0.57 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.24 | -0.26 | N/A | N/A |
| EBITDA(a) | $-15,968 | $-11,792 | $-12,501 | $-14,068 | $-13,614 |